Compositions, methods and kits for repressing virulence in gram positive bacteria

• US 8,202,695 B2
• Filed: 02/23/2007
• Issued: 06/19/2012
• Est. Priority Date: 08/25/2004
• Status: Expired due to Fees

• Current Assignee: Tufts University
• Original Assignee: Tufts University
• Inventors: Sonenshein, Abraham L.
• Primary Examiner(s): Navarro, Albert
• Assistant Examiner(s): Portner, Ginny
• Application Number:
  US11/710,339
• Publication Number:
  US 20070142318A1
• Time in Patent Office: 1,943 Days
• Field of Search: None
• US Class Current: 435/6.13
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 31/198 Alpha-amino acids, e.g. alanine or edetic acid [EDTA] betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00
• CPC Class Codes: A61K 31/522 having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
• CPC Class Codes: A61K 31/7076 containing purines, e.g. adenosine, adenylic acid
• CPC Class Codes: A61K 45/06 Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• CPC Class Codes: A61K 47/183 Amino acids, e.g. glycine, EDTA or aspartame
• CPC Class Codes: A61K 47/26 Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
• CPC Class Codes: A61P 31/04 Antibacterial agents
• CPC Class Codes: Y02A 50/30 Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Bacterial virulence is repressed by compositions and methods for activating permanently a repressor of virulence factors. Compositions provided contain at least one non-metabolizable analog of guanine, guanosine, isoleucine and valine.

Claims

1. A method for identifying an agent for decreasing expression of virulence factors in a culture of Gram positive bacteria, the method comprising:

contacting a first sample of the culture of the bacteria with an analog of guanine or guanosine, or a non-metabolizable analog of amino acid isoleucine or a non-metabolizable analog of amino acid valine, the analog being present at a concentration effective to activate repression by CodY, wherein the culture comprises at least one strain of the bacteria grown in a chemically defined minimal medium, and wherein a second sample of the culture not so contacted and otherwise identical serves as a control; and

analyzing in the first sample and the second sample expression of a CodY regulated gene product, wherein the CodY-regulated gene product is an RNA or a protein, wherein the RNA is an mRNA, wherein decreased expression of the gene product in the first sample compared to expression of the gene product analyzed in the second sample identifies the analog as an agent for limiting expression of virulence factors in cells of the culture of the Gram positive bacteria.

2. The method according to claim 1, further comprising analyzing expression of the gene product in a third sample of the culture of the bacteria contacted with isoleucine and guanine or guanosine which is a positive control, wherein decreased expression in the first sample and third sample compared to the second sample further identifies the analog as the agent.

3. The method according to claim 1, wherein expression in the first sample is at least one selected from the group of:

less than about 75% of that in the second sample, less than about 50% of that in the second sample, and less than about 25% of that in the second sample.

4. The method according to claim 1, wherein the sample is a culture of at least one species selected from the group of a Bacillus, a Clostridium, a Listeria, a Staphylococcus, a Streptococcus, a Desulfitobacterium, a Carboxydothermus, an Enterococcus, a Lactococcus, a Lactobacillus, and a low G+C DNA content Gram positive bacterium.

5. The method according to claim 4, wherein the Bacillus is selected from the group consisting of B. subtilis, B. anthracis, B. cereus, B. popilliae, B. halodurans, B. stearothermophilus and B. thuringiensis.

6. The method according to claim 1, wherein the mRNA is a transcript of a gene selected from the group consisting of dppA and ilvB.

7. The method according to claim 1, wherein the CodY-regulated gene product is a genetic fusion to a marker gene.

8. The method according to claim 7, wherein the marker gene is selected from the group consisting of a gene encoding a β

-galactosidase, a β

-glucuronidase, an alkaline phosphatase and a fluorescent protein.

9. The method according to claim 1, wherein the medium further comprises a chemically defined nitrogen source.

10. The method according to claim 1, wherein the medium further comprises at least one amino acid selected from the group consisting of:

alanine, arginine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, lysine, methionine, phenylalanine, praline, serine, threonine, and tryptophan.